---
source_pdf: "https://drive.google.com/file/d/125u-D983w5uVB4VeCuiFPLVg5OORoAAf/view?usp=drivesdk"
drive_folder: "Portfolio/Evvy"
type: portfolio
company: Evvy
ingested: 2025-12-26
original_filename: "Evvy - Seed - June 2021.pdf"
---

> **Original:** [View Original PDF](https://drive.google.com/file/d/125u-D983w5uVB4VeCuiFPLVg5OORoAAf/view?usp=drivesdk)

## Slide 1: Evvy

Evvy

CONFIDENTIAL
2021

## Slide 2: THE GENDER HEALTH GAP PERSISTS

THE GENDER HEALTH GAP PERSISTS

Women weren't in clinical research until 1993.

Today, we are diagnosed 4 years later than men on average for 770+ diseases.

## Slide 3: MEET EVVY

Evvy

MEET EVVY
We're taking the guesswork out of women's health by discovering and leveraging **new biomarkers** in the female body, starting with the vaginal microbiome.

## Slide 4: THE VAGINAL MICROBIOME

THE VAGINAL MICROBIOME
The unexplored key to female health issues.

Yet â€” women don't have access to this info about our own bodies, and the system doesn't use it to make better decisions.

(Visual: Overlapping bubbles representing conditions linked to the Vaginal Microbiome)
*   Bacterial Vaginosis
*   STI Acquisition
*   Yeast Infections
*   Endometriosis & PCOS
*   Pre-term Birth
*   Recurrent UTIs
*   Pelvic Inflammatory Disease
*   Cervical Cancer
*   IVF Success / Fertility

## Slide 5: Know what's up down there.

(Image of hands holding an Evvy vaginal health test kit box)

Text on box:
The female body shouldn't be a medical mysteryÂ¹
@EVVYBIO
Â¹Women weren't included in US clinical research until 1993. It takes us 4 years later than men to be diagnosed on average for 770+ diseases. Less than 4% of all healthcare funding goes towards women's health. We can only imagine what's possible when we give women the same quality of healthcare. (But we ran out of room on the box.)

Know what's up â†‘down there.â†“

The Evvy Vaginal Health Test demystifies what's up down there, why it matters to your health, and what you can do about it.

Simultaneously, we're generating the largest, longitudinal dataset on the vaginal microbiome, unlocking groundbreaking insights on how to detect and treat a variety of critical health conditions.

## Slide 6: OUR FIRST USERS

OUR FIRST USERS
Evvy provides answers for the millions of women dealing with vaginal infections.

| Condition               | Statistic                                                                                              |
| :---------------------- | :----------------------------------------------------------------------------------------------------- |
| **30%**                 | of women will get BV, 80% will recur within 3 months of treatment.                                     |
| **75%**                 | will get a yeast infection, 8.5% will become recurrent.                                                |
| **50%**                 | will get a UTI, 30% will become recurrent.                                                             |
| *Recurrent = getting an infection 3-4x+ per year* | (Note: This is a footnote for the statistics above)                                          |

## Slide 7: A VICIOUS CYCLE

A VICIOUS CYCLE
The journey to relief is excruciating.
Vaginal health issues interrupt joy â€” daily.

**DEBILITATING PHYSICAL / MENTAL TOLL**
Symptoms + anxiety

*Social Media Post 1*
I can't tell you how many nights I've cried over the strain these chronic yeast infections have caused my relationship. We can never get in the mood because we're always scared it might come back. We can never have sex because we're scared it will come back. I can't tell you how many nights I cried, "Why me? Why is my body like this?".
When will it end? I wish my body wasn't like this. I wish I didn't have to deal with it. But, it makes me feel better knowing that a lot of you are going through the same thing as me. I realize, I'm not as alone as I thought I was. Thank you.
â¤ï¸ 14 Like ðŸ’¬ 24 Comments
View 10 more comments
Girl. Same. ðŸ˜­ It is the root of my depression.
Like Reply 28m

*Social Media Post 2*
Hi.. new to the group and honestly I'm a little embarrassed.... I couldn't believe I found a support group like this... I was diagnosed with BV about a month ago and I had a baby 18 months ago that's when it started after I had her. The smell is so strong that I am so embarrassed I can't even wear leggings. I recently stopped having sex with my husband because I literally gag and cry of the embarrassment the smell causes.... I have NO stds, hormones are balanced, and nothing else came up in my lab work.. what can I do?
â¤ï¸ 2 ðŸ’¬ 27 Comments

*Social Media Post 3*
I'm new to the group. I'm so stressed out. I've lost my fiance because he feels I have contracted a disease from being unfaithful. I haven't even talked to anyone because of feeling so insecure about what I'm going thru. I've been eating yogurt and taking pro/prebiotic gummies and taking apple cider vinegar with the mother gummies...ladies, please help!! Am I doing what's right or hurting myself. I HATE being wet like this and the itching and burning sensation is the WORST!!! I'M a truck driver who don't have much time to stop and go to the doctor but I've been 3 times since last month for the same thing and nothing has helped thus far. Please help!!
ðŸ˜­ 23 ðŸ’¬ 87 Comments

**INEFFECTIVE CARE**
Confusion + misdiagnoses

*Social Media Post 4*
I've been wanting to post about this... ladies If you've been dealing with BV and nothing has helped and your doctor has no answers please get tested for both ureaplasma and mycoplasmas. If your doctor refuses to test you for these find a OB that will. This could be the reason for your bv struggles! Some OB's don't test for this and I don't understand why but it's a real thing. I had BV for 4/5 YEARS!! I had no idea that I had Ureaplasma and that was the cause for my reoccurring bv. I don't think I'm fully healed from my ureaplasma yet but I'm going to get retested soon. Please get tested for this if you haven't already.
â¤ï¸ 12 ðŸ’¬ 13 Comments
View 3 more comments
I get that pain... but my doctor seems to think I've been misdiagnosed with BV for two years...
Idk about anyone else, but sometimes I feel like I know more about this infection than the people treating it.
Like Reply 2d

*Social Media Post 5*
Tested negative for ureplasma but I honestly wanna be tested again. I was tested while on the first day of my period which could've messed with test results. Doctor dosnt wanna test again and won't give me meds. I'm literally going to order doxy online. Can all of you who have had it tell me what meds they were given and for how long and if it worked ?
â¤ï¸ 4

*Social Media Post 6*
If I have yeast does that mean I don't have cytolytic vaginosis or too much lactobacilli? I'm taking doxy for urethra burning and ureaplasma but it causes yeast and i want to use kefir and probiotics but i'm also afraid to over do it .... any differences in the symptoms?

## Slide 8: OUR TESTING METHODS ARE AN ORDER OF MAGNITUDE BETTER.

|                                                                                                                                                                             | PCR (Doctor's Office) | 16S (Other Tests) | METAGENOMICS (Evvy) |
| :-------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | :-------------------- | :---------------- | :------------------ |
| Can look for the presence of a specific bacteria in a sample                                                                                                                | âœ…                     |                   | âœ…                   |
| Exploration of what's there vs. identifying pre-determined pathogens                                                                                                        |                       | âœ…                 | âœ…                   |
| Sequences the entire metagenome, yielding information on all organisms present in the sample (including fungi) rather than only a variable region                             |                       |                   | âœ…                   |
| Ability to identify rare or novel organism in the community                                                                                                                 |                       |                   | âœ…                   |
| Achieves strain level taxonomic resolution - uncover insights into targeted therapeutics (probiotic strains likely to work)                                                 |                       |                   | âœ…                   |
| Evvy also has an exclusive bioinformatics partnership with the largest microbiome lab for analyzing this type of vaginal data                                                 |                       |                   | âœ…                   |

## Slide 9: Evvy is relevant for life.

Evvy is relevant for life.

The vaginal microbiome affects experiences and health outcomes throughout our lifetimes.

(Visual progression of life stages)
Evvy ----------- Puberty ----------- Pregnancy ----------- Menopause ----------- Preventative Health

## Slide 10: OUR VALUE PROPOSITION

OUR VALUE PROPOSITION

### Discover your microbiome.
(Image of phone screen showing Evvy app with "Nicole, meet your microbiome.")
We use metagenomic sequencing to tell you what microbes are present, and which protective bacteria might be missing.

### Optimize your wellness.
(Image of phone screen showing Evvy app with list of bacteria and percentages)
| Microbe                         | Percentage | Category    |
| :------------------------------ | :--------- | :---------- |
| Gardnerella vaginalis            | 53.25%     |             |
| Lawsonella clevelandensis       | 10.34%     |             |
| Atopobium                       | 9.11%      |             |
| Mobiluncus                      | 8.83%      |             |
| Prevotella disiens              | 8.74%      |             |
| Lactobacillus iners             | 5.03%      |             |
| Corynebacterium                 | 2.98%      |             |
| Corynebacterium pyruviciproducens | 1.72%      |             |
| **REDUCE DISRUPTIVE**             |            |             |
| You may want to try Boric Acid    |            | (Recommendation) |

We give you much more than just numbers â€” our results give you personalized and actionable recommendations.

### Track changes over time.
(Image of phone screen showing Evvy app with two bar charts comparing dates)
**05/17/21**
*   Protective: ~72%
*   Neutral: ~19%
*   Disruptive: ~7%
*   Unknown: ~3%

**09/10/21**
*   Protective: ~87%
*   Neutral: ~6%
*   Disruptive: ~4%
*   Unknown: ~1%

By retesting, you can see how your interventions and lifestyle changes are helping your microbiome or not.

## Slide 11: DISCOVER â€¢ OPTIMIZE â€¢ TRACK

DISCOVER â€¢ OPTIMIZE â€¢ TRACK
A shift from process of elimination to personalized discovery.

Presently, a doctor would have to order 7+ swabs to get results on a mere subset of the things Evvy picks up with a single swab.

(Image of phone screen showing Evvy app with "Hannah, meet your microbiome." results)

**MAY 17, 2021**
Hannah, meet your microbiome.

| Microbe               | Percentage | Category   |
| :-------------------- | :--------- | :--------- |
| Lactobacillus crispatus | 41.12%     | PROTECTIVE |
| Prevotella bivia      | 10.34%     | NEUTRAL    |
| Corynebacterium       | 9.11%      | NEUTRAL    |
| Gardnerella vaginalis  | 8.73%      | DISRUPTIVE |

**WHAT TO KNOW**
*   Research has shown that Gardnerella vaginalis may be associated with bacterial vaginosis. G. vaginalis can catalyze an inflammatory immune response and damage vaginal cells.
*   It can also develop biofilm (a sticky, strong layer of infection cells) leading to difficult-to-treat bacterial vaginosis. The biofilm created by G. vaginalis may help other disruptive bacteria grow such as Atopobium.
*   Symptoms of the presence of this bacteria include abnormal discharge such as grey color or watery texture.

**ASSOCIATIONS**
*   BACTERIAL VAGINOSIS (BV)
*   PREGNANCY COMPLICATIONS
*   CAN IMPACT FERTILITY
*   YEAST INFECTION

Prevotella bivia 6.55% (Note: This percentage seems to be cut off or part of a scrolling list, so it's noted as seen.)

## Slide 12: DISCOVER â€¢ OPTIMIZE â€¢ TRACK

DISCOVER â€¢ OPTIMIZE â€¢ TRACK
Actionable results & recommendations based on your unique health context.

Hi Priyanka, here are your next steps.
We've studied thousands of academic papers, treatment ingredient lists, best-of listicles, and moreâ€”all to make sure this plan is personalized to you. We'll keep this page updated as we uncover more through our research!

---
**REDUCE DISRUPTIVE**
âœ… You may want to consider talking to your doctor about **reducing the disruptive bacteria.**
*   Given you are experiencing symptoms, you can talk to your doctor about exploring ways to reduce the disruptive bacteria in your vagina in order to improve the strength of your vaginal defense.
*   LEARN MORE +
*   RESEARCH STATUS: Established

---
**REDUCE DISRUPTIVE**
âœ… You may want to consider talking to your doctor about **boric acid.**
*   Always consult with your doctor before taking boric acid to confirm that it can help you fight or prevent infections from recurring. Boric acid is currently defined as a bacteriostatic or fungistaticâ€”meaning that it stops bacteria or yeast from continuing to grow.
*   LEARN MORE +
*   RESEARCH STATUS: Emerging

---
**PROMOTE PROTECTIVE**
âœ… You may want to try **Taking Probiotics**
*   "You may want to talk to your doctor about incorporating vaginal-specific probiotics to promote the good bacteria in your vaginal microbiome. While the research is new and emerging, there are some promising results but it all comes down to the specific strains..."
*   LEARN MORE +
*   RESEARCH STATUS: Novel

---
**MAINTENANCE**
âœ… You may want to consider **using condoms.**
*   You probably knew using a condom helps reduce the risk of STIsâ€”turns out research shows that it can also reduce your risk for vaginal infections like BV. How? Condoms prevent semen from entering and increasing your vaginal pH...
*   LEARN MORE +
*   RESEARCH STATUS: Established

---
**MAINTENANCE**
âœ… You may want to consider **adjusting habits around sex.**
*   "You probably know a few of these, but here are some best practices from our research team to reduce your risk of infections when you're sexually active: -Pee (or shower) after sex to help clear the urethra of pathogens..."
*   LEARN MORE +
*   RESEARCH STATUS: Established

---
With a constantly evolving database of thousands of bacteria, studies, health outcomes, treatments, and behavior changes, Evvy equips you with what you specifically can do to optimize your vaginal health.

## Slide 13: DISCOVER â€¢ OPTIMIZE â€¢ TRACK

DISCOVER â€¢ OPTIMIZE â€¢ TRACK
Contextualizing results with comparison to past test results and peer groups.

(Image of Evvy app interface comparing test results)
**COMPARE MY TEST FROM** May 17, 2021 **TO** Type 3 â†“

**Your results from May 17, 2021**
(Bar chart showing categories and percentages for May 17, 2021)
*   Protective: 20%
*   Neutral: ~75%
*   Disruptive: ~3%
*   Unknown: ~1%

*   Your type was: Type 3-B
*   Your discharge was: Green, Gray
*   Your smell was: Fishy
*   You were diagnosed with: BV Within 60 Days

**Results for an average Type 3**
(Bar chart showing categories and percentages for average Type 3)
*   Protective: 89%
*   Neutral: 9%
*   Disruptive: 1%
*   Unknown: 1%

*   **DOMINATED BY** Lactobacillus iners
*   **ABOUT** L. iners take up space on the vaginal wall and produce L-lactic acid, both of which help limit the growth of pathogens.
*   **PREVALENCE** Very common
*   **HEALTH OUTCOMES** Associated with both wellness and dysbiosis
*   **FYI** L. iners may be less protective compared to the other Lactobacillus strains.

**Legend:** PROTECTIVE | NEUTRAL | DISRUPTIVE | UNKNOWN

+ HOVER ON DATA TO COMPARE â†’

Helping members track changes over time so they can stop spending money on treatments that don't work.

## Slide 14: PATH TO INTERVENTION

PATH TO INTERVENTION
We're designing first ever customized, vaginal probiotic.
All powered by our proprietary collection of physiological, physical, and molecular data.

(Flow diagram with three components)

**Bacteria/fungi abundance and microbial community composition**
*   Gardnerella vaginalis: 53.25%
*   Lawsonella clevelandensis: 10.34%
*   Atopobium: 9.11%
*   Mobiluncus: 8.83%
*   Prevotella disiens: 8.74%
*   Lactobacillus iners: 5.03%
*   Corynebacterium: 2.98%
*   Corynebacterium pyruviciproducens: 1.72%

**+ Metadata (eg. symptoms, birth control type, BMI, sexual activity, etc.)**
*   Since you told us you use hormonal birth control...
*   Since you told us you're Pregnant
*   Since you told us you've been diagnosed with PCOS

**-> Precise formulation & dosing based on longitudinal data**
(Image of an "Evvy PROBIOTIC SUPPLEMENTS" bottle)

## Slide 15: From our 30 early access members...

From our 30 early access members...

**100** (Circle graphic with gradient)
**NPS**
On the scale of 0-10, 17 people gave us a 10, 2 gave a 9, 1 gave an 8

**100%** (Circle graphic with gradient)
**DESIRE TO RETEST**
50% want to test every 3 months, 30% want to test every month, 20% want to test every 6 months

**100%** (Circle graphic with gradient)
**WILLINGNESS TO PAY**
45% willing to pay $100-150 per test, 35% willing to pay $50-99 per test, 25% willing to pay up to $50

**66** (Quote graphic)
"I finally have an explanation that no doctor has been able to offer me in the past. Because of Evvy, I now have an "action plan" to ... hopefully keep me UTI-free!"
â€” ELIZABETH F

## Slide 16: EARLY RESULTS

EARLY RESULTS
We've set a path to sustainable traction.
What we've seen from our waitlist and soft launch

| Metric          | Value                                   |
| :-------------- | :-------------------------------------- |
| **1000+** waitlist | folks joined the Evvy waitlist since March |
| **$2-3** CAC    | cost of conversion onto our waitlist from initial ad testing |
| **100** invite-only | sales in the first week on our limited "founding member" kits off our waitlist |

## Slide 17: EARLY RESULTS

EARLY RESULTS
Healthcare providers are already incorporating Evvy's unique platform.

In Aug 2021, Evvy will be co-launching a new "Whole Person Exam" with Tia focused on advanced testing and taking control of your preventative care.

We're also in discussions with other systems to offer Evvy as:
*   Preventative wellness screening for patients
*   Part of employee wellness programs
*   A comprehensive, doctor-ordered test for chronic patients

(Logos: Northwell HealthÂ®, Tia)

## Slide 18: PLATFORM OPPORTUNITY

PLATFORM OPPORTUNITY
At even marginal adoption, Evvy's dataset is valuable.

The largest dataset on the vaginal microbiome is 400 women.

(Visual: Overlapping bubbles representing the vaginal microbiome, similar to page 4)

*   **Distribution of data-informed test & therapeutic**
    *   e.g. Partnering with fertility clinics & hospitals to increase IVF success / reduce PTB risk
*   **Precision, predictive biomarkers & early diagnostics**
    *   e.g. Identifying biomarkers for cervical cancer
*   **Precision therapeutics**
    *   e.g. Developing precision vaccine for BV
*   **Member-facing recommendations**
    *   Our dataset helping each member uncover their unique symptoms, risks, and personalized recommendations.

## Slide 19: THE WAY FORWARD

THE WAY FORWARD
Test the individual. Study the data. Build the future.
Our test helps the patient find treatment. At scale, the data defines an entire category.

(Three-phase visual roadmap)

**PHASE 1**
(Image of Evvy Vaginal Health Test kit box)
*   **DTC & B2B**
*   **Vaginal Microbiome test**

**PHASE 2**
(Image of an Evvy PROBIOTIC SUPPLEMENTS bottle)
*   **DTC & B2B**
*   **Custom Probiotics**

**PHASE 3**
(Image of abstract overlapping bubbles, representing a platform)
*   **B2B**
*   **Platform**

## Slide 20: COMPANY TAM

| Phase                  | TAM (Total Addressable Market) | Addressable Women (annual) | Revenue per customer per year | Unit Economics / Margin | Distribution                                        |
| :--------------------- | :----------------------------- | :------------------------- | :---------------------------- | :---------------------- | :-------------------------------------------------- |
| **Phase 1 â€“ Vaginal Microbiome Test** | **$12.74B**                   | 41.7 M                    | $306                          | ~15% margin across one-off + subscription |                                                     |
| **Phase 2 â€“ Custom Probiotics**    | **$8.9B**                     | 99.16 M                   | $90                           | 70%+ margin             |                                                     |
| **Phase 3 â€“ Platform**         | **$19B**                      |                           |                               |                         | B2B (healthcare providers, insurance co/ payers)    |
| *Platform Breakdown:*      | $13.9B for selling test + probiotics to improve outcomes |                           |                               |                         |                                                     |
|                            | $2.3B for precision biomarker dev |                           |                               |                         |                                                     |
|                            | $2.9B for precision therapeutics |                           |                               |                         |                                                     |

## Slide 21: THE WAY FORWARD

THE WAY FORWARD
We're building a repeatable playbook.
The vaginal microbiome is just the beginning.

(Visual progression of different microbiomes/biomarkers)

**Vaginal Microbiome**
*   Finding microbial biomarkers with a single swab.

(Dotted line connecting the images)

**Saliva**
**Blood**
**Urine**
**Gut Microbion** (Text cut off, likely "Microbiome")
*   Building our unique dataset on female-specific biomarkers with a suite of at-home tests

## Slide 22: MARKET LANDSCAPE

|                       | Evvy                 | Juno                     | MicroGen                |
| :-------------------- | :------------------- | :----------------------- | :---------------------- |
| **Sequencing accuracy** | Metagenomics         | 16S                      | 16S                     |
| **Recommendations for user** | Personalized health associations, education, & recs | None                     | None                    |
| **Interventions**     | Path to precision probiotics | No                       | No                      |
| **Distribution**      | DTC subscriptions, OBGYN network, & B2B partners | DTC only, no subscription | Through doctors only    |
| **Dataset**           | Vaginal microbiome + holistic health metadata + path to future tests | Vaginal microbiome + vaginal metadata | Vaginal microbiome only |
| **Price point**       | $99-129              | $149                     | $199                    |

## Slide 23: OUR TEAM

OUR TEAM

**Priyanka Jain**
CEO & Co-founder
PREVIOUSLY
*   Head of Product at pymetrics
    *   Hired & led a tech team of 70+ (engineers, data scientists, product managers). Established 6 product lines across 100+ global enterprise clients. Raised $65M.
*   Stanford University
    *   B.S. Business & Engineering
    *   Mayfield Fellow; President, Stanford Women in Business

**Laine Bruzek**
CMO & Co-founder
PREVIOUSLY
*   Team Lead at Google Creative Lab
    *   Spearheaded initiatives across branding & marketing, emerging tech, data privacy, and product strategy
*   Chief of Staff at Tribeca Enterprises
*   Stanford University
    *   M.S. Management Science & Engineering
    *   B.S. Product Design
    *   Mayfield Fellow

**Pita Navarro**
Head of Clinical Research & Ops
PREVIOUSLY
*   Founding team & Head of Clinical Ops at Athelas
    *   Led FDA 510(k) approval & clinical validation within oncology & psychiatry. Established first pharma partnerships & product implementation throughout healthcare system
*   UCLA
    *   B.S. Molecular Biology

**Fedor Garin**
Engineering Lead (part time)
Previously: Director of Engineering at pymetrics

**Lian Fumerton-Liu**
Design Lead (part time)
Previously: Seed, care/of, byHumankind, Aplos

**Dana Alloy**
R&D Lead (part time)
M.S. in Women's Health (UCL), led largest global study of active women & menstrual health in partnership with Strava

**Diversigen**
Lab Partner
First US lab to establish microbiome protocols in accordance with CLIA

**Two-N**
Data Visualization Lead
Award-winning data viz agency

## Slide 24: OUR ADVISORS

OUR ADVISORS

**Dave Asprey**
Founder & Chairman, Bulletproof
Dave is a four-time New York Times bestselling science author and host of the Webby award-winning podcast Bulletproof Radio.
Over the last two decades Dave, the "Father of Biohacking", has worked with world-renowned doctors, researchers, scientists and global mavericks to uncover the latest, most innovative methods, techniques and products for enhancing mental and physical performance.

**Dr. Craig Cohen**
Professor, Ob/Gyn & Reproductive Sciences, UCSF; Co-Director, University of California Global Health Institute
Dr. Cohen has studied the vaginal microbiome and its impact on reproductive health for 28 years.
He led the first investigation to demonstrate an association between women with BV and HIV, and since has been researching opportunities to optimize the vaginal microbiome and improve reproductive health outcomes including the prevention of HIV acquisition.

**Dr. Diana Currie**
Faculty Ob/Gyn, Providence, Chair of Health Equity for WA Medical Commission, LGBTQ+ Healthcare expert
A board-certified Ob/Gyn, Dr. Currie attended Harvard Medical School where she received an Albert Schweitzer Fellowship in pediatric and adolescent gynecology with a focus on maternal and reproductive health disparities.
She is also well versed in Functional Medicine and believes that every individual deserves a personalized, whole person approach in achieving their optimum health.

**Dr. Ava Mainieri**
Head of Research @ Tia
Harvard geneticist with deep expertise female reproductive health
Propelled by purpose, she leads research at Tia in order to bring forth the relevant clinical and scientific literature required to deliver integrated and comprehensive medical care to women. Previously, she completed her PhD under Dr. David Haig at Harvard University.

**Professor Londa Schiebinger**
Stanford University, Hinds Professor
Director, Gendered Innovations in Science, Health & Medicine, Engineering, & Environment
Schiebinger is a leading international expert on gender in science & technology and has addressed the United Nations and the European Parliament on that topic.
Gendered Innovations harnesses the creative power of sex, gender, and intersectional analysis to enhance excellence and reproducibility in science and technology.

**Dr. Momo Vuyisich**
Co-founder and Chief Science Officer at Viome, previously head of Applied Genomics @ Los Alamos National Lab
Momo is an entrepreneur-scientist who is obsessed with building a healthier future. He has used his extensive scientific expertise and business acumen to lead the development of the core Viome technologies.
Momo obtained his PhD in Chemistry from the University of Utah. He is an adjunct professor at New Mexico Tech University.

## Slide 25: WHERE WE'VE BEEN

WHERE WE'VE BEEN
Key Achievements

(Timeline of achievements)

**JAN 2021**
*   Priyanka & Laine team up

**MAR**
*   Pita joins
*   Launched waitlist

**APR**
*   Ran beta with 30 women
*   Built custom bio-informatics pipeline

**MAY**
*   Finalized Science Advisory Board
*   IRB approved
*   1k on waitlist

**JUNE (Today)**
*   Physical & digital products completed
*   Soft launch into waitlist with first paying customers

**Q3 2021**
*   Public launch
*   Tia partnership live

## Slide 26: WHERE WE'RE GOING

WHERE WE'RE GOING
Goals for this raise

We're raising $4M to reach the following milestones before our Series A:

**1. CONSUMER BRAND & DTC DISTRIBUTION (25% OF BUDGET)**
*   Establish Evvy as a trusted voice of authority on women's health and the vaginal microbiome
*   Establish baseline CAC/LTV by testing basic & unique DTC strategies

**2. R&D (50% OF BUDGET)**
*   Customize probiotic formulations, run study, and start distribution
*   Determine first biomarkers in our dataset
*   Further customize consumer care plan based on dataset

**3. B2B / CLINICAL DISTRIBUTION (25% OF BUDGET)**
*   Establish interest in our dataset (e.g. IVF clinics, hospitals, or pharma)
*   Pilot B2B clinic partnership with Tia
*   Establish OBGYN referral network
*   Start on path to insurance coverage and 510(k)

Key hires:
1 engineer, 1 data scientist (bioinformatician),
1 researcher, 1 marketing

## Slide 27: In a category with no past, Evvy owns the future.

In a category with no past, Evvy owns the future.

(Images are illustrative, no direct text or data to extract)

## Slide 28: Appendix

Appendix

## Slide 29: STANDARD & UNIQUE DTC APPROACHES

STANDARD & UNIQUE DTC APPROACHES
Promoting brand awareness, educating on vaginal health, and creating advocates across channels

**BRAND BUILDING + AWARENESS**
*   **Social**
    *   Owned Social + paid/promoted
*   **Search**
    *   SEO Optimization and Paid Search for underserved, high volume keywords (e.g. mycoplasma)
*   **Email Marketing**
*   **Affiliate Marketing**
*   **Influencer Marketing**
    *   Microinfluencers in naturopath, wellness, chronic illness, biohacker, and similar communities
*   **PR & Earned Media**
*   **Conferences**

**EDUCATION + COMMUNITY BUILDING**
*   Evvy Advocacy Council
*   Community Facebook Group
*   Educational Content
*   Instagram Content
*   Customer Referral Program